Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases

Arthritis and Rheumatism
K NozawaH Hasimoto

Abstract

To assess levels of soluble Fas (sFas) and soluble Fas ligand (sFas-L) in sera from patients with various rheumatic diseases: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), polymyositis/dermatomyositis (PM/DM), mixed connective tissue disease (MCTD), and Sjogren's syndrome (SS). Levels of sFas and sFas-L were determined by a sandwich enzyme-linked immunosorbent assay. In SLE, PM/DM, MCTD, and SS, sFas levels were significantly higher compared with normal controls. Levels of sFas in the SLE patients were significantly higher than in patients with other rheumatic diseases. Levels of sFas-L were significantly increased in SS patients. SLE and RA patients with high levels sFas-L tended to have high levels of sFas, while sFas and sFasL levels did not correlate in patients with other diseases. In some of the SLE patients, sFas and sFas-L levels decreased following steroid therapy. Serum sFas and sFas-L levels were significantly higher in some rheumatic disease patients. Since these changes are complex in these rheumatic diseases, it may be difficult to directly relate sFas and sFasL to their pathogenesis.

References

Dec 1, 1995·The Journal of Experimental Medicine·N KayagakiH Yagita
Oct 1, 1994·The Journal of Experimental Medicine·M G CifoneR Testi
Mar 1, 1996·Nature Medicine·M TanakaS Nagata
Dec 1, 1995·Arthritis and Rheumatism·N GoelM F Seldin

❮ Previous
Next ❯

Citations

Dec 28, 1999·The British Journal of Ophthalmology·K Ohtsuka, M Hashimoto
Sep 1, 2001·Immunology·A Di SabatinoG R Corazza
Nov 27, 2004·Annals of the Rheumatic Diseases·M N Lub-de HoogeM Bijl
Apr 1, 2002·Environmental Health and Preventive Medicine·Akiko TomokuniAyako Ueki
Mar 23, 2017·BioMed Research International·Jiao LuoGuixiu Shi
Dec 14, 1999·Clinical and Experimental Immunology·A TomokuniA Ueki
May 22, 2001·The British Journal of Dermatology·B Baima, M Sticherling
Jul 4, 2002·The American Journal of Gastroenterology·M RiveroF Pons-Romero
Jan 15, 2008·Clinical and Experimental Immunology·C-S LeeP-N Hsu
Aug 20, 2014·Environmental Health and Preventive Medicine·Suni LeeTakemi Otsuki
Feb 26, 2000·Annual Review of Genetics·S Nagata
May 19, 2005·Journal of Periodontology·P ImirzalioĝluD Uckan
Nov 24, 2011·Clinical & Developmental Immunology·Boel De PaepeJan L De Bleecker
Jan 28, 2017·BioMed Research International·Reeta KangasMarko T Korhonen
May 26, 2001·AIDS Research and Human Retroviruses·F SilvestrisF Dammacco
May 18, 2000·American Journal of Hematology·U EmmeneggerK A Neftel
Mar 24, 2005·World Journal of Gastroenterology : WJG·Yu-Liang WangZhi Yao
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A RiccioliE Ziparo
Apr 6, 2017·Clinical Rheumatology·Bernadete L LiphausMagda Carneiro-Sampaio
Aug 15, 2018·International Journal of Molecular Sciences·Hideki NakamuraAtsushi Kawakami
Oct 1, 2004·World Journal of Gastroenterology : WJG·Ning-Li LiDong-Qing Zhang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.